Characteristic of patients
CLI
From April 2022 to August 2022, 15 patients with CLI were recruited for the clinical trial to determine their eligibility for study enrolment. Of these, 11 patients received treatment with P-MSCs, and eight patients completed the trial. Three patients were excluded from the study because of clinical worsening (Fig. Flowchart: 15 patients recruited in the study and allocated to two groups (low-dose group = 3; high-dose group = 8)Comparison of clinical outcome on baseline and 6 months after implantation of P-MSCs